Oxytocin Exerts Antidepressant-like effect by potentiating dopaminergic synaptic transmission in the mPFC

Neuropharmacology. 2020 Jan 1:162:107836. doi: 10.1016/j.neuropharm.2019.107836. Epub 2019 Nov 1.

Abstract

Oxytocin (OT) and dopamine (DA) are two important elements that are closely related to mental and reward processes in the brain. OT controlled DA functional regulation contributes to various behaviours such as social reward, social cognition and emotion-related behaviours. Previous studies indicated that diminished dopaminergic transmission in the medial prefrontal cortex (mPFC) is correlated with the pathophysiology of depression. However, the interaction of OT and DA and their roles in antidepressant effects still require further exploration. Here, we investigated the antidepressant effect of OT through local mPFC administration, and further explored the underlying mechanisms that indicated that OT could strengthen dopaminergic synaptic transmission with OT receptor (OTR) activation dependent in the mPFC. Our results showed that local administration of OT in the mPFC exerts antidepressant (-like) effects in both naïve and social defeat stress (SDS) depressive animal model. Mechanism study suggested that OT enhances DA level with OTR activation dependent, and elevated mPFC DA levels might further enhance excitatory synaptic transmission by activating the D1/PKA/DARPP32 intracellular signalling pathway in the mPFC. Hence, our study revealed that the activation of OTR strengthens excitatory synaptic transmission via the potentiation of dopaminergic synaptic transmission, especially via D1R activation dependent, in the mPFC, which may be the underlying mechanism of antidepressant (-like) effects mediated by OT. With specifically activation of the D1/PKA/DAPRR32 signalling pathway, our results may augment the important role of OT in reward circuits in the central nervous system.

Keywords: Antidepressant effect; Dopamine; Oxytocin; mPFC.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antidepressive Agents / pharmacology*
  • Behavior, Animal / drug effects
  • Cyclic AMP-Dependent Protein Kinases / metabolism
  • Depression / metabolism*
  • Depression / psychology
  • Disease Models, Animal
  • Dopamine / metabolism*
  • Dopamine and cAMP-Regulated Phosphoprotein 32 / metabolism
  • Excitatory Postsynaptic Potentials / drug effects*
  • Male
  • Mice
  • Open Field Test
  • Oxytocin / pharmacology*
  • Prefrontal Cortex / drug effects*
  • Prefrontal Cortex / metabolism
  • Pyramidal Cells / drug effects
  • Receptors, Dopamine D1 / metabolism
  • Receptors, Oxytocin / agonists
  • Receptors, Oxytocin / metabolism
  • Signal Transduction
  • Social Defeat
  • Stress, Psychological / metabolism*
  • Stress, Psychological / psychology
  • Synaptic Transmission / drug effects*

Substances

  • Antidepressive Agents
  • Dopamine and cAMP-Regulated Phosphoprotein 32
  • Receptors, Dopamine D1
  • Receptors, Oxytocin
  • Oxytocin
  • Cyclic AMP-Dependent Protein Kinases
  • Dopamine